Literature DB >> 1753089

Natural antibodies can inhibit bone marrow engraftment in the rat----mouse species combination.

I Aksentijevich1, D H Sachs, M Sykes.   

Abstract

Specific tolerance can be induced in animals by transplanting hemopoietic cells across concordant species barriers. Despite the fact that the rat-mouse species combination is considered concordant, we have recently demonstrated that normal murine serum contains natural antibodies (nAb), predominantly of the IgM and IgG3 subclasses, with markedly greater binding to rat bone marrow cells (BMC) than to rat splenocytes or thymocytes. Since much greater numbers of rat BMC than of allogeneic murine BMC are required to achieve engraftment in mice, we considered the possibility that these nAbs might be responsible, and that the increased numbers of BMC might be required to absorb these nAb. To evaluate the effect of these nAb on engraftment of rat BMC in mice, we have now performed adoptive transfer studies using T and B cell-deficient severe combined immunodeficiency disease (SCID) mice as recipients. Administration of as few as 5 x 10(5) T cell-depleted rat BMC led to induction of stable xenochimerism in SCID mice conditioned with 4-Gy whole body irradiation. Rat T cells developed after a delay of several weeks, and conferred the ability to reject non-donor-type rat skin grafts, whereas donor-type grafts were accepted. Adoptive transfer of 4 ml of normal BALB/c serum led to a marked reduction in the level of rat chimerism in SCID recipients of 2 x 10(6) F344 BMC. The ability of sera to inhibit engraftment of rat BMC correlated with their cytotoxic nAb content, and the inhibitory effect of highly cytotoxic sera could be overcome by administration of large numbers of rat BMC. Thus, normal mouse serum has a limited ability to hinder engraftment of rat BMC, and this degree of resistance can be overcome by adsorption when large numbers of BMC are administered. Eliminating nAb from serum may be more difficult in discordant species combinations in recipients with functional B cells, but may likewise permit the use of BMT as a means of inducing transplantation tolerance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1753089

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts.

Authors:  M Tsugita; A S Rao; H Sun; Y Wakizaka; J Madariaga; F Pan; A J Demetris; J J Fung; T E Starzl; L A Valdivia
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

2.  Tissue-specific posttranslational modification allows functional targeting of thyrotropin.

Authors:  Keisuke Ikegami; Xiao-Hui Liao; Yuta Hoshino; Hiroko Ono; Wataru Ota; Yuka Ito; Taeko Nishiwaki-Ohkawa; Chihiro Sato; Ken Kitajima; Masayuki Iigo; Yasufumi Shigeyoshi; Masanobu Yamada; Yoshiharu Murata; Samuel Refetoff; Takashi Yoshimura
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

Review 3.  A Special Connection between γδ T Cells and Natural Antibodies?

Authors:  Willi K Born; Yafei Huang; Wanjiang Zeng; Raul M Torres; Rebecca L O'Brien
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-05-27       Impact factor: 4.291

4.  Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.

Authors:  H Ohdan; Y G Yang; A Shimizu; K G Swenson; M Sykes
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 5.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

6.  Persistence of anti-HLA antibody after cord blood transplantation engraftment in acute myelogenous leukemia: a potential marker of minimal residual disease, but not a significant factor in secondary humoral engraftment failure.

Authors:  Takumi Hoshino; Satoru Takada; Kenichi Tahara; Hiroaki Shimizu; Nahoko Hatsumi; Shuichi Miyawaki; Tohru Sakura
Journal:  Int J Hematol       Date:  2013-03-03       Impact factor: 2.490

Review 7.  Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.

Authors:  Carrie Gibbons; Megan Sykes
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 8.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.

Authors:  Y Nishimura; M Eto; T Maeda; K Hiromatsu; N Kobayashi; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 10.  Xenotransplantation tolerance: applications for recent advances in modified swine.

Authors:  Nathaly P Llore; Karina A Bruestle; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2018-12       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.